Featuring: Everything AI can change in pharma; Putting patient centricity into practice; GDPR; 25 years of Marketer of the Year
Can pharma prove that being patient centric is more than just a fad?
Celebrating 25 years of the Marketer of the Year competition
How machine learning technology could significantly change the role played by life sciences in the future
The implications of GDPR on pharma and its relationship with healthcare professionals
The PharmaTimes International Clinical Researcher of the Year Awards Ceremony & Gala Dinner is to take place next Thursday (17 May) at the Millenium Gloucester Hotel in London's Kensington.
US regulators have finally issued a green light for AstraZeneca’s Lokelma as a treatment for hyperkalaemia - elevated potassium levels in the blood - in adult patients.
21st May 2018
GlaxoSmithKline has released long-term data showing that its biologic Nucala significantly decreased exacerbations in patients with severe, eosinophilic asthma as well as improvement in disease control.
21st May 2018
The European Medicines Agency has concluded that the risks linked with use of Biogen and AbbVie's multiple sclerosis drug Zinbryta outweigh its benefits.
21st May 2018
Prime Minister Theresa May has revealed new plans to prevent thousands of cancer deaths and improve the detection of chronic diseases through greater use of artificial intelligence.
21st May 2018
Amgen and Novartis’ Aimovig has become the first anti-CGRP therapy to win regulatory clearance in the US, winning approval for migraine prevention.
18th May 2018
What advances in drug delivery devices are in store for us over the next 20-30 years?
Two women in senior pharma leadership roles at talk about their career progression, their experience as women in the industry and progress for women generally
The developers expanding the Cambridge Biomedical Campus explain how a cross-sector community of organisations is working to deliver better patient outcomes
How NHS Scotland is tackling health literacy to better serve patients and what pharma can do to help
New machine learning technologies may have far-reaching, unexpected effects on IP and patent law
Celebrating 25 years of the Marketer of the Year competition
ViiV Healthcare has once again topped the annual PatientView corporate reputation survey. Dr Oleksandr Gorbenko, the company’s director, global patient affairs, explains the company’s views on how pharma should build trust with patients
With over 25 years experience in clinical development and as an eClinical thought leader and strategist, Bill Byrom is an expert on innovating clinical research. Now he has joined CRF Health as vice president of product strategy & innovation to define their product development vision
A look at the exciting breakthroughs in using microscopic interventions to beat cancer
The implications of GDPR on pharma and its relationship with healthcare professionals
Can pharma prove that being patient centric is more than just a fad?
Sanofi’s Milind Kamkolkar is the first enterprise chief data officer in a major pharmaceutical company, and he has been outspoken about the need for pharma to adapt to the new digital world of AI, real-world evidence and prolific data. We caught up with him on the show floor at eyeforpharma Barcelona 2018
Medical conferences provide one of the most valuable opportunities for pharma to engage with key stakeholders, but until recently, it was extremely difficult to gather and analyse relevant information from conference data
It seems as if the conversation around the nature of healthcare’s AI future is one that’s been conducted without the voices of patients themselves
Patient support programmes (PSPs) provide one of the biggest opportunities for pharma to put a patient-centric philosophy into practice
It all starts with listening to patients
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
